Comments

Zhengye Biotechnology

Q: What sector and industry does Zhengye Biotechnology (ZYBT) operate in?

Zhengye Biotechnology is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ZYBTNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.73

0.040.85%

At close: -

$4.68

-0.05-1.06%

After Hours: 9:05 AM EDT

Zhengye Biotechnology (ZYBT) Forecast

News Earnings Zhengye Biotechnology (ZYBT) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Zhengye Biotechnology (NASDAQ:ZYBT) Stock Quotes, Forecast and News Summary

Zhengye Biotechnology Stock (NASDAQ: ZYBT) stock price, news, charts, stock research, profile.

Open	$4.64
Close	$4.73
Volume / Avg.	26.06K / 618.54K
Day Range	$4.60 - $4.88
52 Wk Range	3.70 - 6.10
Market Cap	$220.74M
P/E Ratio	79.95
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$4.64
Close	$4.73
Volume / Avg.	26.06K / 618.54K
Day Range	$4.60 - $4.88
52 Wk Range	3.70 - 6.10
Market Cap	$220.74M
P/E Ratio	79.95
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	-

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Zhengye Biotechnology (ZYBT) stock?

You can purchase shares of Zhengye Biotechnology (NASDAQ:ZYBT) through any online brokerage.

View our list of the best stock brokerages

Who are Zhengye Biotechnology (ZYBT) competitors?

Other companies in Zhengye Biotechnology’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Bioage Labs (NASDAQ:BIOA), Terns Pharma (NASDAQ:TERN) and Neumora Therapeutics (NASDAQ:NMRA).

What is the forecast, or price target, for Zhengye Biotechnology (ZYBT) stock?

There is no analysis for Zhengye Biotechnology to provide a consensus price target.

What is the current price for Zhengye Biotechnology (ZYBT)?

The stock price for Zhengye Biotechnology (NASDAQ: ZYBT) is $4.68 last updated January 17, 2025 at 9:05 AM EST.

Does Zhengye Biotechnology (ZYBT) pay a dividend?

There are no upcoming dividends for Zhengye Biotechnology.

When is Zhengye Biotechnology (NASDAQ:ZYBT) reporting earnings?

Zhengye Biotechnology does not have any upcoming earnings scheduled.

Is Zhengye Biotechnology (ZYBT) going to split?

There is no upcoming split for Zhengye Biotechnology.

What sector and industry does Zhengye Biotechnology (ZYBT) operate in?

Zhengye Biotechnology is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.